Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial ...

Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the ...

The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...